Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Biohaven Ltd.

NYSE: BHVN · Life Sciences · 5 alerts · CIK 1935979

Share price
$13.80Close, Nov 16
Market cap
$2.08B
Shares outstanding
151.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Biohaven Ltd. filings on SEC EDGAR ↗

5:19 PM ET 8-K
Licensing Deal

Biohaven Licensing Deal with Ono Pharmaceutical Co., Ltd. Worth $100M

Biohaven granted Ono Pharmaceutical an exclusive license to develop and commercialize its MoDE pan IgG degrader portfolio, including lead candidate BHV-1300, in Japan, South Korea, Taiwan, and ASEAN countries. Biohaven receives an $80 million upfront payment and is eligible for a $20 million milestone payment plus royalties of approximately 20% on net sales in the territory.

Value
$100M
Counterparty
Ono Pharmaceutical Co., Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.